Recent News

• 03.30.2026 - BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
• 03.25.2026 - BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine
• 03.11.2026 - BullFrog to Host Webinar on New Precision AI Capability
• 02.04.2026 - BullFrog AI to Unveil New Precision AI Capability
• 01.27.2026 - BullFrog AI on Data Harmonization: The Hidden Prerequisite for Reliable AI/ML in Life Sciences
• 01.06.2026 - BullFrog AI-Driven Precision Oncology Analytics Identifies 3x Increase in Overall Survivability in Patient Subgroups through Key Biomarkers in Pancreatic Cancer
• 12.30.2025 - BullFrog AI Publishes Annual Letter to Shareholders
• 11.18.2025 - BullFrog AI Publishes Whitepaper on AI in Bioinformatics: Turning Complex Data into Actionable Insights
• 11.12.2025 - BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025
• 10.30.2025 - Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on October 30

Recent Filings

• 03.19.2026 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.23.2026 - 8-K Current report
• 02.17.2026 - 8-K Current report
• 12.30.2025 - 8-K Current report
• 12.30.2025 - EX-99.1 EX-99.1
• 12.01.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 11.25.2025 - EFFECT Notice of Effectiveness
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.07.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 10.24.2025 - 8-K Current report